Development of an Oral Vaccine Against Enterotoxigenic Escherichia coli Diarrhea
Although enterotoxigenic Escherichia coli (ETEC) is the most common cause of diarrhea in developing countries and in travelers to these areas, there is no ETEC vaccine available for use in humans. In developing countries ETEC diarrhea is mainly seen in children below 5 years and it has been estimated that as many as 650 million cases occur annually among these children, resulting in approximately 800.000 deaths . ETEC is also the cause of 30–50% of all diarrheas in travelers to Latin America, Africa and Asia [1, 2, 3], i.e. between 2 and 3 million cases each year.
KeywordsOral Immunization Cholera Vaccine COLI Diarrhea ETEC Strain ETEC Infection
Unable to display preview. Download preview PDF.
- 1.R.E. Black, The epidemiology of cholera and enterotoxigenic E. coli diarrheal disease, in: “Development of vaccines and drugs against diarrhea,” 11th Nobel Conference, Stockholm, J. Holmgren, A. Lindberg and R. Mollby, eds., Studentlitteratur, Lund, p23 (1986).Google Scholar
- 2.R.L. Guerrant, Microbial toxins and diarrhoeal disease: introduction and overview, in: “Microbial toxins and diarrhoeal disease,” Ciba Foundation Symposium 112, Pitman, London, p1 (1985).Google Scholar
- 7.M.M. Levine, R.E. Black, M.L. Clements, D.R. Nalin, L. Cisneros, and R.A. Finkelstein, Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review, in: “Acute Enteric Infections in Children. New prospects for treatment and prevention”, T Holme, J. Holmgren, M.H. Merson, R. Möllby, eds., Elsevier/North-Holland Biomedical Press, Amsterdam, p 443 (1981).Google Scholar
- 13.J. Clemens, D. Sack, J.R. Harris, J. Chakraborty, P.K. Neogy, B. Stanton, et al., Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. Infect. Dis. 158:372 (1988).CrossRefGoogle Scholar